Related Experiment Videos
Treatment of metastatic uveal melanoma: review and recommendations
D M Albert1, A S Niffenegger, J K Willson
1David G. Cogan Eye Pathology Laboratory, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston.
Abstract:
This article reviews the published clinical responses of metastatic uveal melanoma and metastatic cutaneous melanoma with visceral involvement to current therapeutic protocols. Despite isolated patient responses to systemic treatment, no effective treatment currently exists for metastatic uveal melanoma. However, several new approaches involving interferons and interleukin and combination chemotherapy have shown some activity against metastatic cutaneous melanoma. The effectiveness against metastatic uveal melanomas has not been determined. A new approach to intrahepatic administration of chemotherapy also warrants further evaluation because of the high incidence of hepatic involvement with metastatic uveal melanoma. When an effective systemic treatment is found, early administration as an adjuvant to primary treatment may provide the best strategy for control of systemic spread.
Insights
No effective treatment currently exists for metastatic uveal melanoma, though some therapies show promise for metastatic cutaneous melanoma. Further research into intrahepatic chemotherapy is warranted for uveal melanoma with liver involvement.
Area of Science:
- Oncology
- Dermatology
- Ophthalmology
Background:
- Metastatic uveal melanoma and cutaneous melanoma with visceral involvement present significant treatment challenges.
- Current therapeutic protocols offer limited efficacy for these advanced melanoma types.
Purpose of the Study:
- To review published clinical responses of metastatic uveal and cutaneous melanoma to existing treatments.
- To identify potential therapeutic strategies for metastatic melanoma, particularly uveal melanoma with hepatic involvement.
Main Methods:
- Review of published clinical data on systemic treatments for metastatic uveal and cutaneous melanoma.
- Analysis of responses to current therapeutic protocols, including chemotherapy, interferons, and interleukin.
Main Results:
- Isolated patient responses observed, but no consistently effective systemic treatment for metastatic uveal melanoma identified.
- Interferons, interleukin, and combination chemotherapy show some activity in metastatic cutaneous melanoma.
- Effectiveness of these approaches against metastatic uveal melanoma remains undetermined.
Conclusions:
- Metastatic uveal melanoma lacks effective systemic treatment options.
- Intrahepatic chemotherapy administration warrants further investigation due to high hepatic metastasis rates in uveal melanoma.
- Early adjuvant systemic therapy may be crucial for controlling spread once effective treatments are established.